2.4 HBA measurement Blood samples collected on the 100th and 138th days of the gestation
Sign up to reveal Get instant access to this and all our scores and recommendations Get Digital access 9.99 per month, cancel at any time
Singh shares five tried-and-true techniques to get your heart back on beat
Disclosures: Matthew Menkart: Nothing to Disclose, James Haddad: Nothing to Disclose, Moumita Chakraborty: Nothing to Disclose, Rownock Afruza: Nothing to Disclose, Jenna Oringher: Nothing to Disclose, Gabriella Quinn: Nothing to Disclose, Elizabeth Townsend: Nothing to Disclose, Kareen Akiva: Nothing to Disclose, Lisa Scheuing: Nothing to Disclose, Rabab Ali: Nothing to Disclose, Christopher Koh: Nothing to Disclose, Regina Umarova: Nothing to Disclose, Elliott Levy: Nothing to Disclose, Etzion Ohad: Nothing to Disclose, David Kleiner: Nothing to Disclose, Theo Heller: Nothing to Disclose 549 TAILORING HCC RISK STRATIFICATION IN CHRONIC HEPATITIS C PATIENTS FOLLOWING VIRAL ERADICATION: A SIMPLE ALGORITHM UTILIZING ALPHA-FETOPROTEIN Yen-Chun Liu 1 Yu-Ting Kao 1 Ya-Ting Cheng 1 Yi-Cheng Chen 1 Yi-Chung Hsieh 1 Rachel Wen-Juei Jeng 1 Wei-Ting Chen 1 Chun-Yen Lin 1 Rong-Nan Chien 1 Dar-In Tai 1 I-Shyan Sheen 1 , 1 Chang Gung Memorial Hospital, Linkou branch Background: Guidelines recommend hepatocellular carcinoma (HCC) surveillance for chronic hepatitis C (CHC) patients with advanced liver fibrosis (ACLD) who achieve sustained virological response (SVR) due to an annual HCC incidence 1%
Caizares-Villanueva RO
